As obesity rates continue to rise globally, the search for effective and sustainable weight loss solutions remains a pressing concern
This was an exploratory analysis of the IIH:Pressure trial, the power calculation has been published [19]
Many patients starting GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) wonder: does your stomach shrink on GLP-1 therapy
While Ozempic is highly effective, it is not always the best GLP1 option for every individual
DC-L was supported by the National Science Foundation Graduate Research Fellowship Program under Grant No
In univariable and multivariable analyses, age, race, ethnicity, baseline BMI, diabetes diagnosis, breast cancer stage, histology, breast cancer subtype, and menopausal status were not significantly associated with having 5% or greater weight loss at 12 months after GLP-1 RA initiation ( Figure )